Skip to main content
. 2024 Sep 24;25(1):2398801. doi: 10.1080/15384047.2024.2398801

Figure 1.

Figure 1.

CD8HTM and CD28HTM GUCY2C CAR-T Production. (a) designs of CD8HTM and CD28HTM CARs. (b-i) CD8HTM and CD28HTM CAR constructs used were from 14-day manufacturing of CAR-T cells from n = 6 donors and matched comparisons between CARs. (b-c) expansion and viability of CD8HTM and CD28HTM CAR-T cell products. (d) CD8+ and CD4+ populations among CAR-transduced T cells. Flow cytometry plots shown. (e) Transduction efficiency (% GFP+) and construct expression (GFP MFI) for all 6 donors. (f-g) comparison of transduction efficiency (f) and construct expression (g) between CD8+ and CD4+ T cells for each CAR. (h-i) comparison of transduction efficiency (h) and construct expression (i) between CD8HTM and CD28HTM CARs for CD8+ and CD4+ T cells. All statistical comparisons are paired T-tests; symbols connected with a line represent a matched donor.